TNS Healthcare expands global team

Share this article:
TNS Healthcare has announced two new appointments.

Susanne Michel will lead TNS's global market access, pricing and reimbursement practice, and Mark Sales will head the company's global stakeholder management practice.

Michel's new role will be to provide market research consulting solutions to assist pharmaceutical and biotech companies in driving optimal access at optimal price points in markets around the world. 

Sales will concentrate on TNS's stakeholder management offerings to enhance clients' corporate reputation and maximize sales efficiency, productivity and performance, according to a TNS statement.

“We are building our global portfolio team around the issues most important to our customers—adding experts who can design and deliver innovative approaches that improve our clients' business results,” said Werner Guminski, global head of portfolio, TNS Healthcare, in a statement.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?